Alveolar type II (ATII) cells are progenitor cells found in alveoli that have the ability to regenerate damaged alveolar epithelium.For the purpose of maintaining alveolar epithelial cell homeostasis and re-epithelialization, they are entangled with the microenvironment.Many transcription factors, mediators, ATII cell habitats, and signaling pathways combine to provide a specific environment that regulates ATII cell activity.The precise process underlying the proliferation and differentiation of ATII cells is yet unknown, however it is known that WNT/β-catenin, YAP/TAZ, NOTCH, TGF-β, and P53 signalling pathways in particular are actively involved.However, people with pulmonary emphysema exhibited an imbalance between proliferation and death of alveolar cells, contributing to the alveolar wall's disintegration and decreased gas exchange.The principal cause of this disease's development is oxidative stress, which is brought on by cigarette smoking.In emphysema, aberrant oxidative stress and inflammatory reactions lead to ATII cell dysfunction and a loss of cell homeostasis.Here, we go over our current knowledge of the pathophysiology of this illness, including abnormal reparative responses and alveolar re-epithelialization. Additionally, included are new and developing medicines, such as cell therapies undergoing clinical trials.
No takes yet. Share an insight, caveat, or question.
Lingolu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: